Adjuvant Therapy of Breast Cancer: An Overview

References

• Goldhirsch A, Wood WC, Senn HJ, Glick JH, Gelber RD. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst 1995; 87: 1441–5.
   Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1-15, 71–85.
   Google Scholar
• Schinzinger A. Ueber carcinoma mammae. Cbl Chr 1889; 16: 55.
   Google Scholar
• Beatson GT. On the treatment of inoperative cases of cari-noma of the mamma. Lancet 1896; 2: 104.
   Google Scholar
• DeCourmelles FV. La radiotherapie indirect, ou dirigee par les correlations organiques. Arch Elect Med 1922; 32: 264.
   Google Scholar
• Taylor GW. Evaluation of ovarian sterilization for breast cancer. Surg Gynecol Obst 1939; 68: 452.
   Google Scholar
• Treves N. An evaluation of prophylactic castration in the treatment of mammary carcinoma. Cancer 1957; 10: 393.
   PubMed Web of Science ®Google Scholar
• Kennedy BJ, Wielke PW Jr, Fortuny IE. Therapeutic castra-tion versus prophylactic castration in breast cancer. Surg Gynecol Obst 1964; 118: 524–40.
   PubMedGoogle Scholar
• Kennedy BJ. Diethylstilbestrol versus testosterone propionate therapy in advanced breast cancer. Surg Gynecol Obst 1965; 120: 1246–50.
   PubMedGoogle Scholar
• Kennedy BJ, Kelley RM, White G, Nathanson IT. Surgery as an adjunct to hormone therapy of breast cancer. Cancer 1957; 10: 1055–75.
   PubMed Web of Science ®Google Scholar
• Kiang DT, Kennedy BJ. Tamoxifen (antiestrogen) therapy in advanced breast cancer. Ann Intern Med 1977; 87: 687–90.
   PubMed Web of Science ®Google Scholar
• Ingle JN, Ahmann DL, Green SJ, et al. Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Eng J Med 1981; 304: 16–21.
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Wood WC, Senn HJ, et al. International consensus conference on primary treatment of breast cancer. Recent Results Cancer Res 1996; 140: 325–35.
   PubMedGoogle Scholar
• Forbes JF. The control of breast cancer: the role of tamox-ifen. Semin Oncol 1997; 24 (Suppl 1): S1-5, S1–19.
   Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Ovarian ablation in early breast cancer: Overview of the randomized trials. Lancet 1996; 348: 1189–96.
   Google Scholar
• Fisher B, Carbone P, Economou SG, et al. 1-phenylalanine mustard (L-PAM) in the management of primary breast cancer. N Eng J Med 1975; 292: 117–22.
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Brusamoline E, Valagussa P, et al. Combina-tion chemotherapy as an adjuvant treatment in operable breast cancer. N Eng J Med 1976; 294: 405–10.
   PubMed Web of Science ®Google Scholar
• NCI Monographs. Proceedings of the NIH. Consensus Devel-opment Conference on Adjuvant Chemotherapy and En-docrine Therapy for Breast Cancer. Bethesda, MD: National Institute of Health, 1986.
   Google Scholar
• Fisher B, Redmond C, Elias EG, et al. Adjuvant chemother-apy for breast cancer: an overview of NSABP findings. Int Adv Surg Oncol 1982; 5: 65–90.
   PubMedGoogle Scholar
• Fisher B, Brown A, Mamounas E, et al. Preoperative chemotherapy reduced the size of most breast tumors de-creased the incidence of positive nodes. J Clin Oncol 1997; 15: 2483–93.
   PubMed Web of Science ®Google Scholar
• Norton L. Conceptual basis for advances in the systemic drug therapy of breast cancer. Semin Oncol 1997; 24 (Suppl 11): 2–12.
   Google Scholar
• Paterson R. Breast cancer--a report of two clinical trials. J Royal Coll Sur Edin 1962; 7: 243–54.
   PubMedGoogle Scholar
• Stjernswärd J. Can survival be decreased by postoperative irradiation. Int J Radiat Oncol Biol Phys 1977; 2: 1171–5.
   PubMed Web of Science ®Google Scholar
• Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 15–25.
   PubMedGoogle Scholar
• Holland JF, Gildewell 0, Cooper RG. Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast. Gynecol Obstet 1980; 150: 817–21.
   Google Scholar
• Levitt SH. Is there a role for post-operative adjuvant radia-tion in breast cancer? Beautiful hypothesis versus ugly facts: 1987 Gilbert H. Fletcher lecture. Int J Radiat Oncol Biol Phys 1988; 14: 787–96.
   PubMed Web of Science ®Google Scholar
• Levitt SH. The importance of locoregional control in the treatment of breast cancer and its impact on survival. Cancer 1994; 74: 1840–6.
   PubMed Web of Science ®Google Scholar
• Cuzick J, Stewart H, Rutqvist L. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12: 447–53.
   Google Scholar
• Arriagada R, Rutqvist LE, Mattsson A, et al. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 1995; 13: 2869–78.
   PubMed Web of Science ®Google Scholar
• Auquier A, Rutqvist LE, Host H, Rotstein S, Arriagada R. Postmastectomy megavoltage radiotherapy: the Oslo and Stockholm trials. Eur J Cancer 1992; 28: 433–7.
   Google Scholar
• Wallgren A, Amer 0, Bergstrom J, et al. Radiation therapy in operable breast cancer: results from the Stockholm trial on adjuvant radiotherapy. Int .1- Radiat Oncol Biol Phys 1986; 12: 533–7.
   Google Scholar
• McNeese MD, Fletcher GH, Levitt SH, Khan FM. Breast Cancer. In: Levitt SH, Khan FM, Potish RA, eds. Levitt and Tapley's Technological Basis of Radiation Therapy: Practical Clinical Applications, Second edition. Philadelphia: Lea & Febiger, 1992: 232–47.
   Google Scholar
• Sykes HF, Sim DA, Wong CJ, Cassady JR, Salmon SE. Local-regional recurrence in breast cancer after mastectomy and Adriamycin-based adjuvant chemotherapy: evaluation of the role of postoperative radiotherapy. Int .1- Radiat Oncol Biol Phys 1989; 16: 641–7.
   PubMed Web of Science ®Google Scholar
• Griem KL, Henderson IC, Gelman R, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 1987; 5: 1546–55.
   PubMed Web of Science ®Google Scholar
• Stefanik D, Goldberg R, Byrne P, et al. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1985; 3: 660–5.
   PubMed Web of Science ®Google Scholar
• Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949–55.
   PubMed Web of Science ®Google Scholar
• Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956–62.
   PubMed Web of Science ®Google Scholar
• Recht A, Come SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 1996; 334: 1356–61.
   PubMed Web of Science ®Google Scholar
• Recht A, Harris JR, Come SE. Sequencing of irradiation and chemotherapy for early-stage breast cancer. Oncol 1994; 8: 19–28.
   Google Scholar
• Hartsell WF, Recine DC, Griem KL, Murthy AK. Delay-ing the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer 1995; 76: 2497–503.
   PubMed Web of Science ®Google Scholar
• McCormick B, Norton L, Yao TJ, Yahalom J, Petrek JA. The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery. Cancer Journal Scientific America 1996; 2: 39–45.
   Google Scholar
• Wallgren A, Bernier J, Gelber RD, et al. Timing of radio-therapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. Int J Radiat Oncol Biol Phys 1996; 35: 649–59.
   PubMedGoogle Scholar
• Perez CA, Graham ML, Taylor ME, et al. Management of locally advanced carcinoma of the breast: I. Noninflamma-tory. Cancer 1994; 74: 453–65.
   PubMed Web of Science ®Google Scholar
• Hortobagyi GN. Comprehensive management of locally ad-vanced breast cancer. Cancer 1990; 66: 1367–91.
   Google Scholar
• Singletary SE, McNeese MD, Hortobagyi GN. Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 1992; 69: 2849–52.
   Google Scholar
• Marks LB, Halperin EC, Prosnitz LR, et al. Post-mastec-tomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with 10 positive axillary lymph nodes. Int J Ra-diat Oncol Biol Phys 1992; 23: 1021–6.
   PubMed Web of Science ®Google Scholar
• Peters WP, Ross M, Vredenburgh JJ, et al. High-dose chemotherapy and autologous bone marrow support as con-solidation after standard-dose adjuvant therapy for high-risk primary cancer. J Clin Oncol 1993; 11: 1132–43.
   PubMed Web of Science ®Google Scholar
• Osborne CK, Clark GM, Ravdin PM. Adjuvant systemic therapy of primary breast cancer. In: Harris JR, Lippman ME, Morrow M, Hellman S, eds. Diseases of the breast. Philadelphia: Lippincott-Raven, 1996: 548–78.
   Google Scholar
• Padmanabhan N, Wang DY, Moor JW, et al. Ovarian function and adjuvant chemotherapy for early breast can-cer. Eur J Cancer Clin Oncol 1987; 23: 745.
   PubMedGoogle Scholar
• Gradishar WJ, Schilsky RL. Ovarian function following ra-diation and chemotherapy for cancer. Semin Oncol 1989; 16: 425.
   PubMed Web of Science ®Google Scholar
• Harris JR, Morrow M. Local management of invasive breast cancer. In: Harris JR, Lippman ME, Morrow M, Hellman S, eds. Diseases of the breast. Philadelphia: Lip-pincott-Raven, 1996: 487–547.
   Google Scholar
• Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovas-cular mortality in randomized trial of adjuvant radiation versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992; 22: 887–96.
   PubMed Web of Science ®Google Scholar
• Gyenes G, Gagliardi G, Lax I, Fornander T, Rutqvist LE. Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radio-therapy. J Clin Oncol 1997; 15: 1348–53.
   Google Scholar
• Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 1992; 326: 781–5.
   Google Scholar
• Shapiro CL, Recht A. Late effects of adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 1994; 16: 101–12.
   PubMedGoogle Scholar